试论乳腺癌前乳腺增生态靶辨治策略
Discussion on state-target treatment based on syndrome differentiation strategy for breast hyperplasia before breast cancer
乳腺增生与乳腺癌发病关系密切,部分病变存在恶变风险,对《乳腺影像报告和数据系统》3~4类及以上病变早期干预,是乳腺癌防治关口前移的关键,契合“治未病”理念。本文基于态靶辨治将本病分为病气、病血、病络三期,梳理壅、郁、瘀、虚、络五态的病机与靶方靶药,审态察势、调态打靶,为诊疗提供参考。
Mammary gland hyperplasia is closely related to the onset of breast cancer, with some lesions carrying a risk of malignant transformation. Early intervention for BI-RADS 3–4 and above lesions is crucial for shifting the focus of breast cancer prevention and treatment forward, aligning with the TCM concept of "treating disease before its onset". Based on state-target treatment based on syndrome differentiation, this paper categorizes the disease into pathogenic qi, pathogenic blood and pathogenic collateral stages, and systematically elaborates the pathogenesis, and target prescriptions and herbs of five states (stagnation, depression, stasis, deficiency, collateral blockage), while assessing the state and monitoring the condition to adjust state and targeted therapy, providing a reference for diagnosis and therapy.
| [1] |
HIS M, |
| [2] |
|
| [3] |
|
| [4] |
标准化项目组中成药治疗优势病种临床应用指南. 中成药治疗乳腺增生症临床应用指南(2021年)[J]. 中国中西医结合杂志,2022,42(5):517-524. |
| [5] |
张书毓,吴国柱. 乳腺浅筋膜超声特征可提高BI-RADS 4类结节良恶性鉴别效能[J]. 分子影像学杂志,2026,49(4):434-442. |
| [6] |
American College of Radiology. BI‑RADS® v2025 Manual: Breast Imaging Reporting and Data System[M]. Reston: American College of Radiology,2025:149. |
| [7] |
吴谦.医宗金鉴[M]. 北京:人民卫生出版社,2017. |
| [8] |
崔俊波,田春洪,朱建平. 国医大师张震“疏调气机”治疗甲状腺结节、乳腺增生、子宫肌瘤共病经验[J]. 中医药导报,2026,32(7):172-175,179. |
| [9] |
刘胜,王怡,吴春宇, |
| [10] |
蒋可心,史有阳,刘胜. 刘胜运用“气血水”理论治疗乳腺囊性增生症[J]. 中医学报,2024,39(8):1749-1753. |
| [11] |
刘雅菲,王群,张丽媛, |
| [12] |
张璇,刘雁峰,刘枳男, |
| [13] |
王翰飞,潘孜文,朱向东, |
| [14] |
吕钊岚,陈劼. 基于“六郁”理论指导针刺治疗乳腺增生[J]. 江苏中医药,2024,56(4):50-53. |
| [15] |
张晓清,卞卫和,应语, |
| [16] |
于师文,崔俊波. 从气滞痰凝瘀血辨治良性乳腺结节研究进展[J]. 光明中医,2025,40(3):580-584. |
| [17] |
郭莉,文灼彬,王桂彬, |
| [18] |
邢昊晴,高渝,王颖, |
| [19] |
吴有性.温疫论[M]. 北京:人民卫生出版社,2007. |
吉林省中医药管理局项目-张文风名老中医专家传承工作室(吉中医药发〔2023〕56号)
吉林省自然科学基金项目(YDZJ202601ZYTS521)
/
| 〈 |
|
〉 |